Efficacy News and Research

RSS
Anti-SARS-CoV-2 antibodies suggested to be safe to use in pregnancy

Anti-SARS-CoV-2 antibodies suggested to be safe to use in pregnancy

Increased illness burden of COVID-19 among unvaccinated first responders

Increased illness burden of COVID-19 among unvaccinated first responders

COVID-19 vaccination coverage and breakthrough infections in urban slums of India

COVID-19 vaccination coverage and breakthrough infections in urban slums of India

Study on molnupiravir precursor NHC antiviral activity against SARS-CoV-2 variants of concern

Study on molnupiravir precursor NHC antiviral activity against SARS-CoV-2 variants of concern

Study analyzes the resistance of H. pylori bacterium to antibiotics

Study analyzes the resistance of H. pylori bacterium to antibiotics

Phase I trial evaluates safety, efficacy of astatine for use in alpha therapy for refractory thyroid cancer patients

Phase I trial evaluates safety, efficacy of astatine for use in alpha therapy for refractory thyroid cancer patients

Extended host range for SARS-CoV-2 variants of concern

Extended host range for SARS-CoV-2 variants of concern

Does vaccine or infection induced immunity better protect against SARS-CoV-2 variants?

Does vaccine or infection induced immunity better protect against SARS-CoV-2 variants?

How COVID-19 protection conferred by infection is modified by vaccination

How COVID-19 protection conferred by infection is modified by vaccination

Do we need COVID-19 vaccine boosters?

Do we need COVID-19 vaccine boosters?

Interventions most effective in containing SARS-CoV-2 spread

Interventions most effective in containing SARS-CoV-2 spread

Immunogenicity of modified microparticle-adjuvanted SARS-CoV-2 vaccine

Immunogenicity of modified microparticle-adjuvanted SARS-CoV-2 vaccine

COVID vaccines effectively reduce outbreaks of SARS-CoV-2 alpha and delta viruses in households

COVID vaccines effectively reduce outbreaks of SARS-CoV-2 alpha and delta viruses in households

Study finds no evidence to support favipiravir use in mild or asymptomatic COVID-19 patients

Study finds no evidence to support favipiravir use in mild or asymptomatic COVID-19 patients

Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine

Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine

Antiviral activity of a photoactivable natural product on coronaviruses

Antiviral activity of a photoactivable natural product on coronaviruses

SARS-CoV-2 vaccine based on vesicular stomatitis virus exhibits high neutralizing efficacy against variants

SARS-CoV-2 vaccine based on vesicular stomatitis virus exhibits high neutralizing efficacy against variants

A review of natural immunity, vaccines, and variants in SARS-CoV-2 reinfection

A review of natural immunity, vaccines, and variants in SARS-CoV-2 reinfection

Researchers reveal possible role for anti-idiotype antibodies in long-term effects of COVID-19

Researchers reveal possible role for anti-idiotype antibodies in long-term effects of COVID-19

Study demonstrates effectiveness of two doses of BBV152 vaccine against COVID-19

Study demonstrates effectiveness of two doses of BBV152 vaccine against COVID-19

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.